Cherry Labs Awarded NIH Grant to Help Older Americans Age in Place Independently Using Privacy-protected, AI-based Monitoring

Mom and Dad Want Independence and Peace of Mind at Home? Cherry And NIH Study To Help REDWOOD CITY, Calif.–(BUSINESS WIRE)–Cherry Labs today announced they received a grant from the National Institutes of Health (NIH) and are embarking on a study to help maintain independence for older adults using their AI-driven Cherry Home technology. Cherry … [Read more…]

Biodesix to Present Data at IASLC 2022 World Conference Demonstrating that the VeriStrat® Test is Predictive of Progression Free Survival and Overall Survival in Patients with Low or Negative PD-L1 Treated with Immune Checkpoint Inhibitors

New data emphasizes the utility of the VeriStrat® Proteomic Test to identify patients likely to benefit from Immune Checkpoint Inhibitors BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Young Kwang Chae, MD, MPH, MBA, Associate Professor of Medicine (Hematology and Oncology) … [Read more…]

CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Targeting Platform and Advance Lead Programs into the Clinic

– Proceeds to Support Clinical Development of Lead CNS & Liver Programs; IND for Dravet Syndrome is Anticipated by Mid-2023 – New Capital Will Also Fuel Expansion of CAMP4’s regRNA Actuating Platform™, Harnessing the Power of Regulatory RNA to Upregulate Gene Expression – Funding Round Led by Enavate Sciences, a Portfolio Company of Patient Square … [Read more…]

6-Hour Virtual Seminar on Master Class for the HIPAA Officer – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “6-Hour Virtual Seminar on Master Class for the HIPAA Officer: Protecting Patient Information and Implementing Today’s Privacy, Security, and Breach Regulations” webinar has been added to ResearchAndMarkets.com’s offering. Overview: The session begins with overview of the HIPAA regulations and then continues with presentation of the specifics of the Privacy Rule, such as Individual … [Read more…]

Building a Vendor Qualification Program for FDA Regulated Industries – Online Course – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Building a Vendor Qualification Program for FDA Regulated Industries” training has been added to ResearchAndMarkets.com’s offering. This course will provide detailed explanations and examples for Building a Vendor Qualification Program for FDA Regulated Industry. With today’s pharmaceutical market, raw materials, Active Pharmaceutical Ingredients (API), Containers & Closures, inactive or excipients and other components … [Read more…]

GenSight Biologics reports 5 years’ data showing sustained efficacy and safety following one-time treatment with LUMEVOQ®

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported that after 5 years of follow-up, Leber Hereditary Optical Neuropathy (LHON) subjects treated with LUMEVOQ® (GS010) continued to experience significantly improved … [Read more…]

ATLATL Boosts China’s Life Sciences through Integration of Global Innovation Resources

Five years since its creation, ATLATL has served more than 100 early-stage biotechs and projects. SHANGHAI–(BUSINESS WIRE)–#Shanghai–Celebrating its 5th anniversary, ATLATL proclaims that it will continue contributing to the rapid growth of the life sciences sector in China. The ATLATL Center for Innovation & Research is a biopharmaceutical research-based open innovation platform committed to building … [Read more…]

Daiichi Sankyo Confirms that a Texas Court has Entered Judgment on the Jury Verdict in Seagen Patent Dispute

No Enhancement of Damages Awarded by Court Despite Jury’s Finding of Willfulness TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Co., Ltd. (TSE: 4568) (hereinafter, Daiichi Sankyo) confirmed today that the U.S. District Court for the Eastern District of Texas has entered judgment on the April 8, 2022 jury verdict finding that ENHERTU® infringes Seagen’s U.S. … [Read more…]

MedTech Innovator Names 20 Premier Startups for Annual Asia Pacific Accelerator

LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–#MedTechInnovator—MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry, has announced the 20 companies selected to participate in the organization’s third annual Asia … [Read more…]